WO2006000213A3 - Peptide zur inhibition der interaktion von proteinkinase a und proteinkinase a-ankerproteinen - Google Patents
Peptide zur inhibition der interaktion von proteinkinase a und proteinkinase a-ankerproteinen Download PDFInfo
- Publication number
- WO2006000213A3 WO2006000213A3 PCT/DE2005/001181 DE2005001181W WO2006000213A3 WO 2006000213 A3 WO2006000213 A3 WO 2006000213A3 DE 2005001181 W DE2005001181 W DE 2005001181W WO 2006000213 A3 WO2006000213 A3 WO 2006000213A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein kinase
- peptides
- interaction
- inhibiting
- anchor proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/571,117 US20090104177A1 (en) | 2004-06-29 | 2005-06-29 | Peptides for inhibiting the interaction of protein kinase a and protein kinase a anchor proteins |
CA002571350A CA2571350A1 (en) | 2004-06-29 | 2005-06-29 | Peptides for inhibiting the interaction of protein kinase a and protein kinase a anchor proteins |
EP05763349A EP1763537A2 (de) | 2004-06-29 | 2005-06-29 | Peptide zur inhibition der interaktion von proteinkinase a und proteinkinase a-ankerproteinen |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004031579A DE102004031579B4 (de) | 2004-06-29 | 2004-06-29 | Peptide zur Inhibition der Interaktion von Proteinkinase A und Proteinkinase A-Ankerproteinen, diese umfassendes Nukleinsäuremolekül, Vektor, Wirtszelle, gegen diese gerichtetes Erkennungsmolekül, diese enthaltende pharmazeutische Zusammensetzung, diese enthaltender Kit und deren Verwendung |
DE102004031579.5 | 2004-06-29 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2006000213A2 WO2006000213A2 (de) | 2006-01-05 |
WO2006000213A3 true WO2006000213A3 (de) | 2006-08-24 |
WO2006000213A9 WO2006000213A9 (de) | 2007-03-08 |
Family
ID=35612701
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE2005/001181 WO2006000213A2 (de) | 2004-06-29 | 2005-06-29 | Peptide zur inhibition der interaktion von proteinkinase a und proteinkinase a-ankerproteinen |
Country Status (5)
Country | Link |
---|---|
US (1) | US20090104177A1 (de) |
EP (1) | EP1763537A2 (de) |
CA (1) | CA2571350A1 (de) |
DE (1) | DE102004031579B4 (de) |
WO (1) | WO2006000213A2 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8003111B2 (en) * | 2005-04-06 | 2011-08-23 | Ibc Pharmaceuticals, Inc. | Dimeric alpha interferon pegylated site-specifically shows enhanced and prolonged efficacy in vivo |
TW200745163A (en) * | 2006-02-17 | 2007-12-16 | Syntonix Pharmaceuticals Inc | Peptides that block the binding of IgG to FcRn |
US8906844B2 (en) | 2007-08-09 | 2014-12-09 | Biogen Idec Hemophilia Inc. | Immunomodulatory peptides |
WO2013021384A1 (en) * | 2011-08-11 | 2013-02-14 | Yeda Research And Development Co. Ltd | Compositions and methods for modulating apoptosis |
GB201208775D0 (en) | 2012-05-18 | 2012-07-04 | Uni I Oslo | Chemical compounds |
EP2740484A1 (de) * | 2012-12-05 | 2014-06-11 | Lipotec, S.A. | Verbindungen zur Behandlung und/oder Pflege von Haut, Schleimhautmembranen der Kopfhaut und/oder Haar und deren Verwendung in kosmetischen oder pharmazeutischen Zusammensetzungen |
GB201320506D0 (en) | 2013-11-26 | 2014-01-01 | Uni I Oslo | Cyclic amino compounds for the use in the treatment of cardiac disorders |
WO2016172537A1 (en) * | 2015-04-23 | 2016-10-27 | The Trustees Of The University Of Pennsylvania | Compositions to disrupt protein kinase a anchoring and uses thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10306085A1 (de) * | 2002-09-06 | 2004-03-25 | Forschungsverbund Berlin E.V. | Neue Spleißvariante eines Proteinkinase A-Ankerproteins und Verwendung dieser |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6872645B2 (en) * | 2002-04-02 | 2005-03-29 | Nanosys, Inc. | Methods of positioning and/or orienting nanostructures |
US20040180379A1 (en) * | 2002-08-30 | 2004-09-16 | Northwestern University | Surface-enhanced raman nanobiosensor |
-
2004
- 2004-06-29 DE DE102004031579A patent/DE102004031579B4/de not_active Expired - Fee Related
-
2005
- 2005-06-29 WO PCT/DE2005/001181 patent/WO2006000213A2/de active Application Filing
- 2005-06-29 US US11/571,117 patent/US20090104177A1/en not_active Abandoned
- 2005-06-29 EP EP05763349A patent/EP1763537A2/de not_active Withdrawn
- 2005-06-29 CA CA002571350A patent/CA2571350A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10306085A1 (de) * | 2002-09-06 | 2004-03-25 | Forschungsverbund Berlin E.V. | Neue Spleißvariante eines Proteinkinase A-Ankerproteins und Verwendung dieser |
Non-Patent Citations (3)
Title |
---|
I.D.C. FRASER ET AL.: "A NOVEL LIPID-ANCHORED A-KINASE ANCHORING PROTEIN FACILITATES cAMP-RESPONSIVE MEMBRANE EVENTS", EMBO, vol. 17, no. 8, 1998, pages 2261 - 2272, XP002369143 * |
L.L. BURNS-HAMURO: "DESIGNING ISOFORM-SPECIFIC PEPTIDE DISRUPTORS OF PROTEIN KINASE A LOCALIZATION", P.N.A.S., vol. 100, no. 7, 1 April 2003 (2003-04-01), pages 4072 - 4077, XP002369142 * |
LUTZ VOSSEBEIN: "REGULATION VON SIGNALTRANSDUKTIONSELEMENTEN ÜBER ANKERPROTEINE", 2002, DISSERTATION ZUR ERLANGUNG DES GRADES EINES DOKTORS DER NATURWISSENSCHAFTEN DER FAKULTÄT FÜR BIOLOGIE DER RUHR-UNIVERSITÄT-BOCHUM, XP002369158 * |
Also Published As
Publication number | Publication date |
---|---|
WO2006000213A2 (de) | 2006-01-05 |
WO2006000213A9 (de) | 2007-03-08 |
DE102004031579A1 (de) | 2006-02-09 |
US20090104177A1 (en) | 2009-04-23 |
CA2571350A1 (en) | 2006-01-05 |
DE102004031579B4 (de) | 2012-12-27 |
EP1763537A2 (de) | 2007-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006000213A3 (de) | Peptide zur inhibition der interaktion von proteinkinase a und proteinkinase a-ankerproteinen | |
WO2004024757A3 (en) | Modified pna molecules | |
WO2005003296A3 (en) | Albumin fusion proteins | |
WO2003089456A3 (en) | Peptide inhibitors of protein kinase c | |
WO2007112940A3 (en) | Albumin-derived amino acid sequence, use thereof for increasing the half-life of therapeutic proteins and of other therapeutic compounds and entities, and constructs comprising the same | |
WO2005077042A3 (en) | Albumin fusion proteins | |
IL169367A0 (en) | Defensin proteins | |
WO2006047728A3 (en) | Bmp gene and fusion protein | |
WO2006017355A3 (en) | Improved aprotinin variants | |
WO2005051902A3 (en) | Modified mscl protein channel | |
WO2007000770A3 (en) | Protein kinase c inhibitors for prevention of insulin resistance and type 2 diabetes | |
WO2005059131A3 (en) | Protein binding miniature proteins and uses thereof | |
TW200724679A (en) | Treatment of disease using an improved regulated expression system | |
IL169256A (en) | Polypeptide having metalloprotease activity, nucleic acid encoding it and pharmaceutical composition comprising it | |
WO2006040660A3 (en) | Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof | |
WO2006074914A3 (en) | Human rna helicase and therapeutic uses thereof | |
WO2007039254A3 (en) | Use of fusion proteins for the prevention or the treatment of pathologies resulting from ischemia | |
WO2004053117A3 (en) | Serine protease | |
WO2005079541A3 (en) | Terephthalamide peptidomimetic compounds and methods | |
WO2004009633A8 (en) | Serotonin receptor | |
WO2004050703A8 (en) | Splice variant of the human pituitary growth hormone | |
GB0426960D0 (en) | TGR-3 like protein receptor | |
WO2008012476A3 (fr) | Utilisation de carboxypeptidases dans le domaine cosmetique et therapeutique | |
WO2007134907A3 (en) | Gm-csf gene therapy for treatment of crohn's disease using an improved regulated expression system | |
WO2009071276A3 (de) | Allel- und isotyp-spezifische intervention an mit autoimmunerkrankungen assoziierten mhc-klasse-ii-molekülen durch peptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2571350 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005763349 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWP | Wipo information: published in national office |
Ref document number: 2005763349 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11571117 Country of ref document: US |